GIP (3 - 42) (human)
| Name | GIP (3 - 42) (human) |
| Category | Gastric Inhibitory Polypeptide (GIP) and Fragments |
| One Letter Code | EGTFISDYSIAMDKIHQQDFVNWLLAQKGKKNDWKHNITQ |
| Three Letter Code | {Glu}{Gly}{Thr}{Phe}{Ile}{Ser}{Asp}{Tyr}{Ser}{Ile}{Ala}{Met}{Asp}{Lys}{Ile}{His}{Gln}{Gln}{Asp}{Phe}{Val}{Asn}{Trp}{Leu}{Leu}{Ala}{Gln}{Lys}{Gly}{Lys}{Lys}{Asn}{Asp}{Trp}{Lys}{His}{Asn}{Ile}{Thr}{Gln} |
| Molecular Weight | 4759.400 |
| Application | Diabetes |
| Miyachi, Atsushi, et al. "Quantitative analytical method for determining the levels of gastric inhibitory polypeptides GIP1–42 and GIP3–42 in human plasma using LC–MS/MS/MS." Journal of proteome research 12.6 (2013): 2690-2699. |
| Gault, V. A., et al. "Evidence that the major degradation product of glucose-dependent insulinotropic polypeptide, GIP (3-42), is a GIP receptor antagonist in vivo." Journal of Endocrinology 175.2 (2002): 525-534. |